文献速递脊柱关节炎

血浆蛋白质组学识别强直性脊柱炎高结构损伤的分子特征与生物标志物

Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated With High Structural Damage in Ankylosing Spondylitis.
PubMed 文献 · Arthritis Rheumatol · 2026-09-28

本研究在88人发现队列中采用深度血浆蛋白质组学,按SPARCC骶髂关节结构评分分层比较高结构损伤与低结构损伤强直性脊柱炎患者及正常对照。研究识别出536个差异表达蛋白,并优先筛选出ITGA2B、HSPG2、ITGB1、EPHB2和SAA2五蛋白特征,在独立88人验证队列中联合模型AUC达0.917,显著优于单个生物标志物。结论支持SAA2标记的系统性炎症与ITGA2B相关血小板-细胞外基质重塑部分分离但生物学互联的双通路模型。

要点

  • 五蛋白联合模型在验证队列中AUC为0.917,显著优于单个生物标志物。
  • 高结构损伤组与正常对照间鉴定出536个差异表达蛋白。
  • WGCNA显示结构损伤相关模块富集于血小板活化与细胞-基质黏附。

核心结论

  • 研究支持强直性脊柱炎存在双通路模型:SAA2标记的系统性炎症与ITGA2B相关血小板-细胞外基质重塑部分分离但生物学互联。
  • 验证的五蛋白面板可作为无创工具识别当前高结构损伤患者,补充影像学评估并捕捉生物学异质性。

研究设计与样本

  • 前瞻性88人发现队列,含25例高结构损伤和31例低结构损伤强直性脊柱炎患者及32例正常对照,按SPARCC骶髂关节结构评分分层。
  • 采用年龄和性别校正的差异表达分析、加权基因共表达网络分析(WGCNA)和集成机器学习筛选损伤相关分子程序并优先排序生物标志物。
  • 五个候选蛋白在独立88人队列中通过酶联免疫吸附试验验证,含32例高结构损伤、32例低结构损伤和24例正常对照。

主要发现

  • 蛋白质组分析在高结构损伤组与正常对照间鉴定出536个差异表达蛋白。
  • WGCNA揭示一个结构损伤相关模块富集于血小板活化和细胞-基质黏附,同时强直性脊柱炎相关模块在RNA加工和翻译方面减少。
  • 集成分析优先筛选出由ITGA2B、HSPG2、ITGB1、EPHB2和SAA2组成的五蛋白特征。
  • 联合模型在验证队列中AUC为0.917,显著优于单个生物标志物(AUCs 0.732-0.819;所有Holm校正P < 0.05)。

关键数值与推荐

  • 高/低结构损伤分层依据SPARCC骶髂关节结构评分。
  • 五蛋白联合模型验证队列AUC为0.917,单个生物标志物AUCs为0.732-0.819,Holm校正P < 0.05。

临床怎么用

  • 五蛋白面板可作为无创工具辅助识别当前高结构损伤的强直性脊柱炎患者,补充影像学评估。
  • SAA2标记的系统性炎症与ITGA2B相关血小板-细胞外基质重塑可能为理解结构损伤提供双通路视角。

局限性

  • 发现队列和验证队列各88人,样本量有限。
  • 研究为观察性设计,五蛋白面板的临床效用需进一步前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pathologic bone formation in ankylosing spondylitis (AS) is not fully reflected by systemic inflammation, limiting the utility of markers of inflammation for structural damage assessment. This study aimed to identify plasma protein signatures associated with structural damage severity in AS. METHODS: Deep plasma proteomics was conducted in a prospective 88-participant discovery cohort comprising 25 and 31 patients with high and low structural damage, respectively, stratified by the Spondyloarthritis Research Consortium of Canada sacroiliac joint structural score and 32 normal controls. Age- and sex-adjusted differential expression analysis, weighted gene coexpression network analysis (WGCNA), and integrated machine learning were used to characterize damage-associated molecular programs and prioritize biomarkers. Five candidate proteins were validated by enzyme-linked immunosorbent assay in an independent 88-participant cohort (32 high, 32 low, and 24 normal controls). RESULTS: Proteomic profiling identified 536 differentially expressed proteins between the high structural damage group and normal controls. WGCNA revealed a structural-damage-associated module, enriched in platelet activation and cell-matrix adhesion, together with an AS-associated reduction in a module related to RNA processing and translation. Integrated analysis prioritized a five-protein signature comprising ITGA2B, HSPG2, ITGB1, EPHB2, and SAA2. The combined model achieved an area under the curve (AUC) of 0.917 in the validation cohort and significantly outperformed individual biomarkers (AUCs 0.732-0.819; all Holm-adjusted P < 0.05). CONCLUSION: This study supports a dual-pathway model in which SAA2-marked systemic inflammation and ITGA2B-associated platelet-extracellular matrix remodeling appear partially dissociated yet remain biologically interconnected in AS. The validated five-protein panel provides a noninvasive tool for identifying patients with current high structural damage that complements imaging-based assessment by capturing biologic heterogeneity.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sun T, Liu W, Yang K, et al. Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated With High Structural Damage in Ankylosing Spondylitis. Arthritis Rheumatol. 2026. PMID: 42803182. doi:10.1002/art.70353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。